- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01837953
Stepped Care for Binge Eating Disorder: Predicting Response to Minimal Intervention in a Randomized Controlled Trial
October 3, 2016 updated by: Ottawa Hospital Research Institute
Binge Eating Disorder (BED) affects as many as 3% of women and men in Ontario, 8% of obese individuals, and 30% to 50% of those participating in weight loss programs.
BED, the most common eating disorder, is characterized by over-eating with loss of control (i.e., binge eating), but with no purging (e.g., vomiting).Our previous research indicates that the total health care costs for women with BED is 36% higher than the Canadian average for women of a similar age, and that health care costs significantly decreased following intensive treatment at our Centre.
The main goal of our study is to inform the development of a stepped care approach to the treatment of BED.
Stepped care involves providing easily accessible low intensity treatment first, and then providing more expensive intensive treatment second, if necessary.
The second goal is to assess if a second more intensive step of treatment provides added value.
Although stepped care for BED is suggested by a number of clinicians and researchers, no study adequately tests predictors of who might benefit from minimal treatment alone and who would require the more intensive second step.
The results of this study will guide decision making regarding who benefits from stepped care, and will help to increase the accessibility, availability, and cost effectiveness of psychological treatments for BED.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1H8L6
- Regional Centre for the Treatment of Eating Disorders
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Participants will be included if they:
- are comfortable speaking or reading English;
- do not have a history of an eating disorder other than BED, or a history of significant purging behaviour;
- do not have a concurrent DSM-IV diagnosis of bipolar disorder, psychosis, drug or alcohol dependence;
- are not currently or planning to be enrolled in a weight-loss program within the next year;
- are women who are not pregnant or planning to be pregnant within the next year; and
- are not currently or planning to be enrolled in other psychotherapies within the next year
Exclusion Criteria:
Participants will be excluded if they:
- are not comfortable speaking or reading English;
- have a history of an eating disorder other than BED, or a history of significant purging behaviour;
- have a concurrent DSM-IV diagnosis of bipolar disorder, psychosis, drug or alcohol dependence;
- are currently or plan to be enrolled in a weight-loss program within the next year;
- are women who are pregnant or planning to be pregnant within the next year; and
- are currently or plan to be enrolled in other psychotherapies within the next year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Unguided Self-Help, No Further Treatment for 16 Weeks
All participants will first receive 10 weeks of unguided self-help (USH), followed by no further treatment for 16 weeks.
Participants will be offered a follow up referral to the eating disorders program at The Ottawa Hospital after the 16 week no-treatment period.
|
All participants will first receive 10 weeks of Unguided Self-help.
The USH will be based on Dr. Christopher Fairburn's CBT-oriented and evidence based self-help treatment plan for binge eating explained in his book, Overcoming Binge Eating.
The USH program follows six steps: (1) Getting Started: Self-monitoring, weekly weighing; (2) Regular Eating: Establishing a pattern of regular eating; (3) Alternatives to Binge Eating: Substituting alternative activities; (4) Problem Solving and Taking Stock: Practicing problem solving and reviewing progress; (5) Dieting and Related Forms of Avoidance: Tackling the three forms of dieting and other forms of avoidance eating; and (6) What Next? Preventing relapse and dealing with other problems.
|
EXPERIMENTAL: Unguided Self-Help, GPIP
All participants will first receive 10 weeks of unguided self-help (USH).
For those participants randomized to the USH + Group Psychodynamic Interpersonal Psychotherapy condition, this second step will consist of 16 weekly 90 minute sessions of Group Psychodynamic Interpersonal Psychotherapy.
|
All participants will first receive 10 weeks of Unguided Self-help.
The USH will be based on Dr. Christopher Fairburn's CBT-oriented and evidence based self-help treatment plan for binge eating explained in his book, Overcoming Binge Eating.
The USH program follows six steps: (1) Getting Started: Self-monitoring, weekly weighing; (2) Regular Eating: Establishing a pattern of regular eating; (3) Alternatives to Binge Eating: Substituting alternative activities; (4) Problem Solving and Taking Stock: Practicing problem solving and reviewing progress; (5) Dieting and Related Forms of Avoidance: Tackling the three forms of dieting and other forms of avoidance eating; and (6) What Next? Preventing relapse and dealing with other problems.
For those participants randomized to the USH + Group Psychodynamic Interpersonal Psychotherapy (GPIP) condition, this intervention will consist of 16 weekly 90 minute sessions of GPIP.
GPIP was developed and empirically tested in a randomized controlled trial (RCT) at our Centre.
GPIP will be preceded by an individual pre-group preparation session conducted by a psychologist trained in GPIP to orient the patient to the therapy.
Patients are given a rationale for the treatment.
Examples of the patient's cyclical relational patterns (CRPs) that may underlie their symptoms are discussed and the patient will be encouraged to work on these in the groups.
Therapists will be given a written summary of each patient's CRP.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Binge Eating Episodes in the Past 28 Days.
Time Frame: Up to one and a half years
|
Binge eating is assessed in a structured interview using a calendar recall method (Wilfley et al., 1993).
|
Up to one and a half years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body Mass Index (BMI).
Time Frame: Up to one and a half years
|
This outcome variable will be calculated by dividing weight (kg) by height (m2).
|
Up to one and a half years
|
Center for Epidemiologic Studies Depression Scale (CES-D)
Time Frame: Up to one and a half years
|
The CES-D is a brief self-report measure of depressive symptoms.
|
Up to one and a half years
|
Experiences in Close Relationships Scale (ECR)
Time Frame: Up to one and a half years
|
The ECR, a predictor of USH outcome, is a 36-item measure comprising two 18-item scales (Avoidance and Anxiety).
Items are scored on a 7-point Likert scale, ranging from 1 = Disagree Strongly to 7 = Agree Strongly.
|
Up to one and a half years
|
Inventory of Interpersonal Problems (IIP-64)
Time Frame: Up to one and a half years
|
The IIP-64 assesses interpersonal problems; higher scores indicate greater problems.
The IIP is a 64-item scale with a 5-point Likert-type response format.
|
Up to one and a half years
|
Patient Health Questionnaire 9 (PHQ-9).
Time Frame: Up to one and a half years
|
The PHQ-9 is a 9-item self-report measure.
The PHQ-9 is used in assessing the severity of depressive symptomology and can act as a diagnostic tool (Kroenke et al., 2001).
|
Up to one and a half years
|
Rapid Response to Treatment: Self-Monitoring
Time Frame: From the date of the start of unguided self-help to the end of self-help (Up to 10 weeks)
|
Self monitoring of binge eating is an indicator of rapid response to USH, which is a predictor of USH outcome.
Daily record sheets will be used to assess objective binge eating episodes on an on-going basis throughout the course of USH.
In each daily record, participants record whether they had any overeating behaviors (including objective binge episodes) and how many.
The daily record forms provide a definition of objective binge episodes based on the EDE definition.
These definitions will be reviewed with participants at the start of USH.
|
From the date of the start of unguided self-help to the end of self-help (Up to 10 weeks)
|
Rosenberg Self Esteem Scale (RSES)
Time Frame: Up to one and a half years
|
The RSES, a predictor of USH outcome and an outcome variable, will be used to measure self esteem.
The RSES is a ten-item self-report scale using a four-point response format.
Scores are summed to produce a total score ranging from 0 to 30, with higher scores representing higher self esteem.
|
Up to one and a half years
|
Eating Disorder Diagnostic Scale (EDDS)
Time Frame: From the start of Group Psychodynamic Interpersonal Psychotherapy (GPIP) to the end of GPIP (Up to 16 weeks)
|
This is a self report measure of eating disorder symptoms including binge eating
|
From the start of Group Psychodynamic Interpersonal Psychotherapy (GPIP) to the end of GPIP (Up to 16 weeks)
|
Experiences in Close Relationships Scale Short Form (ECR-S).
Time Frame: From the start of Group Psychodynamic Interpersonal Psychotherapy (GPIP) to the end of GPIP (Up to 16 weeks)
|
The ECR-S, a predictor of USH outcome, is a 12-item measure comprising two 6-item scales (Avoidance and Anxiety).
Items are scored on a 7-point Likert scale, ranging from 1 = Disagree Strongly to 7 = Agree Strongly.
The ECR-S was derived from the full ECR scale which was derived from existing self-report adult romantic attachment measures.
|
From the start of Group Psychodynamic Interpersonal Psychotherapy (GPIP) to the end of GPIP (Up to 16 weeks)
|
Therapeutic Factors Inventory (TFI)
Time Frame: From the start of Group Psychodynamic Interpersonal Psychotherapy (GPIP) to the end of GPIP (Up to 16 weeks)
|
The full 99-item TFI will not be used in its entirety but rather the 9-item subscale of cohesiveness will only be used to measure levels of group cohesion throughout GPIP.
It is a 7-point Likert-type scale with responses ranging from 1 (Strongly Disagree) to 7 (Strongly Agree).
|
From the start of Group Psychodynamic Interpersonal Psychotherapy (GPIP) to the end of GPIP (Up to 16 weeks)
|
Outcome Rating Scale (ORS)
Time Frame: From the start of Group Psychodynamic Interpersonal Psychotherapy (GPIP) to the end of GPIP (Up to 16 weeks)
|
The ORS was originally developed as a shorter form of the Outcome Questionnaire 45.2 (Miller et al., 2003).
The ORS is a 4-item self-report scale that will be used as a treatment outcome measure of GPIP.
|
From the start of Group Psychodynamic Interpersonal Psychotherapy (GPIP) to the end of GPIP (Up to 16 weeks)
|
Working Alliance Inventory Short (WAI-S).
Time Frame: From the start of Group Psychodynamic Interpersonal Psychotherapy (GPIP) to the end of GPIP (Up to16 weeks)
|
The WAI is a 12-item self-report measure of alliance to therapist and in this case the GPIP therapist.
|
From the start of Group Psychodynamic Interpersonal Psychotherapy (GPIP) to the end of GPIP (Up to16 weeks)
|
Eating Disorder Examination - Questionnaire (EDE-Q)
Time Frame: Up to one and a half years
|
The EDE-Q, an outcome scale, is a 28-item self-report measure modeled on the EDE interview (Fairburn & Cooper, 1993).
The EDE-Q Restraint scale measures dietary restraint, Eating Concern scale measures concern about eating, Shape Concern scale measures preoccupation with one's body shape, and Weight Concern scale measures preoccupation with one's body weight (Fairburn & Beglin, 1994)).
The EDE-Q also provides a single overall score of eating disorder psychopathology based on the scales.
|
Up to one and a half years
|
Depression Anxiety and Stress Scales 21(DASS-21)
Time Frame: Up to one and a half years
|
The DASS-21 is a self-report measure of stress, anxiety, and depression.
|
Up to one and a half years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: George A Tasca, Ph.D,C.Psych, University of Ottawa, Ottawa Hospital: General Campus
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (ACTUAL)
September 1, 2016
Study Completion (ANTICIPATED)
September 1, 2017
Study Registration Dates
First Submitted
January 28, 2013
First Submitted That Met QC Criteria
April 18, 2013
First Posted (ESTIMATE)
April 23, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
October 4, 2016
Last Update Submitted That Met QC Criteria
October 3, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20120689-01H
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Binge Eating Disorder
-
University of North Carolina, Chapel HillThe Hilda & Preston Davis Foundation; Global Foundation for Eating DisordersCompletedEating Disorder | Binge-eating DisorderUnited States
-
ShireCompleted
-
Lindner Center of HOPEUniversity of CincinnatiCompleted
-
Sao Jose do Rio Preto Medical SchoolFundação de Amparo à Pesquisa do Estado de São PauloCompletedBinge-Eating Disorder | Eating Disorders | Eating Behavior | Eating Disorder | Binge Eating Disorder Associated With ObesityBrazil
-
Nova Scotia Health AuthorityCompletedBinge-Eating Disorder | Eating DisorderCanada
-
BioprojetRecruiting
-
Lindner Center of HOPEJazz PharmaceuticalsRecruiting
-
Idorsia Pharmaceuticals Ltd.Completed
-
University of ChicagoTakedaCompleted
Clinical Trials on Unguided Self-Help
-
Memorial University of NewfoundlandCompletedBinge Eating DisorderCanada
-
Nova Scotia Health AuthorityCompletedBinge Eating DisorderCanada
-
Indiana UniversityCompletedDepression | Anxiety | Emotion RegulationUnited States
-
Francine RosselliWesleyan UniversityUnknownObesity | Binge Eating DisorderUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
Chinese University of Hong KongNot yet recruitingDepression | Insomnia
-
University of NottinghamUnknownCarer Stress SyndromeUnited Kingdom
-
University of BernCompletedPsychological Distress | Coronavirus | Adjustment, PsychologicalSwitzerland
-
Stanford UniversityNational Institute of Mental Health and Neuro Sciences, IndiaCompleted